Dynasore: Noncompetitive Dynamin GTPase Inhibitor for Endocytosis Research

Executive Summary: Dynasore (SKU A1605, from APExBIO) is a cell-permeable, noncompetitive inhibitor that targets dynamin GTPases with an IC₅₀ of 15 μM (Wang et al., 2018, https://doi.org/10.1186/s12985-018-0993-8). It blocks dynamin-dependent endocytosis by inhibiting GTPase activity in multiple cell types. Its action is reversible, and it is widely used to dissect endocytic pathways and synaptic vesicle recycling. Dynasore is insoluble in water/ethanol, but soluble in DMSO at ≥16.12 mg/mL, and should be stored at −20°C for stability (APExBIO product page). Peer-reviewed studies validate its use in viral entry and vesicle trafficking research (Wang et al., 2018, doi).

Biological Rationale

Dynamin GTPases are essential for the scission of vesicles from cellular membranes during endocytosis. These enzymes, including dynamin1, dynamin2, and Drp1, participate in GTP binding and hydrolysis, which drive membrane fission events. Endocytosis underlies critical processes such as receptor-mediated uptake, signal transduction, and membrane protein recycling. Inhibition of dynamin GTPase activity allows researchers to dissect these pathways with temporal precision. Dynasore's use in cell models, including HL-1 cardiomyocytes and neurons, provides a robust system for studying dynamin-dependent endocytosis and related signaling events (Wang et al., 2018).

Mechanism of Action of Dynasore

Dynasore acts as a noncompetitive inhibitor of dynamin GTPase activity. It binds to dynamin isoforms (dynamin1, dynamin2, Drp1) and impairs their ability to hydrolyze GTP. This inhibition blocks the final membrane scission step during clathrin-mediated endocytosis. The compound does not compete with GTP for binding; instead, it allosterically inhibits the catalytic activity. Dynasore displays an IC₅₀ of 15 μM for dynamin GTPase inhibition under cell-free conditions (APExBIO). The inhibition is reversible: washing out Dynasore from cells restores endocytic uptake within minutes (related article—this review clarifies reversibility benchmarks beyond the present article's mechanistic focus).

Evidence & Benchmarks

• Dynasore at 80 μM significantly inhibits clathrin-mediated endocytosis and viral entry in CIK cells, reducing grass carp reovirus infection efficiency in vitro (Wang et al., 2018, DOI).
• Dynasore reversibly inhibits transferrin uptake in HL-1 cells and neurons, confirming dynamin-dependent endocytosis blockade (APExBIO).
• In viral entry models, Dynasore's inhibition is specific for dynamin-dependent pathways; it does not block dynamin-independent (e.g., caveolar) endocytosis (Wang et al., 2018, DOI).
• Dynasore demonstrates robust cell permeability and maintains activity at 37°C when dissolved in DMSO at ≥16.12 mg/mL (APExBIO).
• Peer-reviewed protocols recommend storage of Dynasore stocks at −20°C for up to several months without loss of inhibitory potency (APExBIO).

This article extends Dynasore (A1605) in Endocytosis Research: Evidence-Driven... by providing detailed, citation-linked benchmarks and clarifying solubility and reversibility parameters that support reproducible research.

Applications, Limits & Misconceptions

Validated Applications:

• Dissection of dynamin-dependent endocytic pathways in mammalian and aquatic cell models.
• Analysis of synaptic vesicle endocytosis and recycling in neurobiology (see also: expanded disease modeling perspectives—this linked article covers disease contexts beyond the cellular mechanisms emphasized here).
• Investigation of viral entry mechanisms, especially for viruses utilizing clathrin-mediated, dynamin-dependent pathways (Wang et al., 2018, DOI).
• Study of vesicle trafficking and protein biosynthesis pathways.
• Signal transduction and membrane protein translocation research.

Common Pitfalls or Misconceptions

• Dynasore does not inhibit dynamin-independent endocytosis (e.g., caveolae-mediated pathways).
• Its inhibitory effect is reversible; removing Dynasore restores endocytosis within minutes.
• Incorrect solvent use (water or ethanol) results in poor solubility; only DMSO provides adequate solubilization (≥16.12 mg/mL).
• Dynasore is for research use only and is not suitable for diagnostic or therapeutic applications.
• Over-interpretation: Dynasore does not directly affect all endocytic or trafficking pathways; specificity for dynamin is established, but off-target effects at high concentrations cannot be excluded (APExBIO).

Workflow Integration & Parameters

For optimal results, prepare Dynasore stock solutions in DMSO (minimum 16.12 mg/mL). Stocks should be warmed to 37°C or sonicated to ensure complete dissolution. Working concentrations typically range from 10–100 μM, depending on the cell model and endpoint. Store aliquots at −20°C; avoid repeated freeze-thaw cycles. In cell-based assays, Dynasore can be added directly to media containing up to 1% DMSO. Removal of Dynasore by medium exchange enables recovery of endocytic activity, facilitating reversible experimental designs (see: detailed workflow best practices—the linked article focuses on troubleshooting and protocol optimization not covered here).

Conclusion & Outlook

Dynasore, as supplied by APExBIO, is a rigorously validated, noncompetitive dynamin GTPase inhibitor. Its specificity and reversibility make it ideal for dissecting vesicle trafficking, endocytosis, and viral entry mechanisms. Peer-reviewed benchmarks confirm its suitability for both basic research and translational studies in neurobiology, cancer, and infectious disease models. Proper solubilization and storage are critical for consistent results. Emerging research continues to refine Dynasore's applications and boundaries, supporting its use as a gold-standard chemical probe in cell biology (Dynasore product page).